Advertisement

The journal of nutrition, health & aging

, Volume 23, Issue 10, pp 1043–1047 | Cite as

Observational Study Investigating the Prescription of Lipid-Lowering Drugs for Primary and/or Secondary Prevention in Residents Aged 80 Years and Over Institutionalized in Nursing Homes in Brest

  • C. PichotEmail author
  • A. Gentric
Article

Abstract

Objectives

To evaluate the prescription of lipid-lowering therapy in nursing home residents aged 80 and older.

Design

Observational descriptive study, led in Brest, France, between February and May 2017.

Setting

15 nursing homes in Brest, France.

Participants

Nursing home residents, aged 80 and older, treated with a lipid-lowering therapy for primary and / or secondary prevention.

Measurements

The primary endpoint was to observe the frequency of prescription of lipid-lowering therapy at the time of the study. The secondary endpoints were to analyse the relevance of these prescriptions regarding the latest French recommendations and current literature data and to evaluate the monitoring of treatment.

Results

213 of the 1121 included residents (19%) were treated with a lipid-lowering drugs. A total of 141 prescriptions (66.2%) were considered irrelevant. In the past 12 months, monitoring of lipids, liver and muscle enzymes was observed respectively in 41.3%, 60.1% and 9.4% of residents.

Conclusion

lipid-lowering prescription was not optimal in nursing homes. The results highlighted inadequate treatment monitoring and a gap between the French National Authority for Health (HAS) recommendations and actual practice.

Key words

Dyslipidemia statins nursing homes overuse; suboptimal 

Notes

Conflict of interest: The authors declares that there is no conflict of interest.

References

  1. 1.
    Institut De Veille Sanitaire. Banque de données en santé publique. http://invs.santepubliquefrance.fr.
  2. 2.
    Centre d’épidémiologie sur les causes médicales de décès (CépiDc). Inserm. Interrogations des données sur les causes de décès de 1979 à 2014. http://www.cepidc.inserm.fr.
  3. 3.
    Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370(9602):1829–39.CrossRefGoogle Scholar
  4. 4.
    Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994;308(6925):367–72.CrossRefGoogle Scholar
  5. 5.
    Kronmal RA, Cain KC, Ye Z, Omenn GS. Total Serum Cholesterol Levels and Mortality Risk as a Function of Age: A Report Based on the Framingham Data. Arch Intern Med. 1993;153(9):1065–73.CrossRefGoogle Scholar
  6. 6.
    Weverling-Rijnsburger AW, Blauw GJ, Lagaay AM, Knook DL, Meinders AE, Westendorp RG. Total cholesterol and risk of mortality in the oldest old. Lancet. 1997;350:1119–23.CrossRefGoogle Scholar
  7. 7.
    Tuikkala P, Hartikainen S, Korhonen MJ, et al. Serum total cholesterol levels and all-cause mortality in a home-dwelling elderly population: a six-year follow-up. Scand J Prim Health Care. 2010;28(2):121–7.CrossRefGoogle Scholar
  8. 8.
    Psaty BM, Anderson M, Kronmal RA, et al. The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study. J Am Geriatr Soc. 2004;52(10):1639–47.CrossRefGoogle Scholar
  9. 9.
    Rumholz HM, Seeman TE, Merrill SS, et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA. 1994;272(17):1335–40.CrossRefGoogle Scholar
  10. 10.
    Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. Circulation. 2014;129(25 suppl 2).Google Scholar
  11. 11.
    Reiner Z, Catapano AL, De Backer G, et al. European Society of Cardiology, European Atherosclerosis Society, European Association for Cardiovascular prevention & Rehabilitation. ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2011;32(14).Google Scholar
  12. 12.
    Haute Autorité de Santé. Principales dyslipidémies: stratégies de prise en charge. Rapport d’élaboration. Saint-Denis La Plaine. 2017. https://www.has-sante.fr/portail/upload/docs/application/pdf/2017-03/dir5/rappot_dyslipidemies_pour_mel.pdf
  13. 13.
    Folstein MF, Folstein SE, McHugh PR. « Mini-mental state ». A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1 nov 1975;12(3):189–98.CrossRefGoogle Scholar
  14. 14.
    Haute Autorité de Santé. Principales dyslipidémies: stratégies de prise en charge. Fiche mémo. Saint-Denis La Plaine. 2017. https://www.has-sante.fr/portail/upload/docs/application/pdf/2017-03/dir5/synthese_fiche_memo_dyslipidemies_v3.pdf
  15. 15.
    Cooney MT, Selmer R, Lindman A, Tverdal A, Menotti A, Thomsen T, et al. Cardiovascular risk estimation in older persons: SCORE O.P. Eur J Prev Cardiol. juill 2016;23(10):1093–103.CrossRefGoogle Scholar
  16. 16.
    French Society of Endocrinology (SFE), Francophone Society of Diabetes (SFD), New French Society of Atherosclerosis (NSFA). Consensus statement on the management of dyslipidaemias in adults. Diabetes Metab. 2016;42(6):398–408.CrossRefGoogle Scholar
  17. 17.
    Haute Autorité de Santé. Efficacité et efficience des hypolipémiants. Une analyse centrée sur les statines. Synthèse. Saint-Denis La Plaine. 2010. https://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/synthese_efficacite_et_efficience_des_hypolipemiants_-_une_analyse_centree_sur_les_statines.pdf
  18. 18.
    Duchesne T. Étude en médecine générale: poursuite de la prescription de statines chez les patients de plus de 80 ans institutionnalisés dans les Landes en 2014. Thèse de médecine. Faculté de médecine. Bordeaux 2. 2015. https://dumas.ccsd.cnrs.fr/dumas-01188073/document.Google Scholar
  19. 19.
    Atramont A, Bourdel-Marchasson I, Bonnet-Zamponi D, et al. Résidents admis en Ehpad au cours du premier trimestre 2013: pathologies prises en charge, traitements et hospitalisations l’année suivante. Bull Epidémiol Hebd. 2017;(16–17):317–27. http://invs.santepubliquefrance.fr/beh/2017/16-17/2017_16-17_4.html.
  20. 20.
    J. S. Kutner, P. J. Blatchford, et al. Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness: A Randomized Clinical Trial. JAMA. 2015;175:691–700.Google Scholar
  21. 21.
    Bain KT, Holmes HM, Beers MH, et al. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc. 2008;56(10):1946–52.CrossRefGoogle Scholar
  22. 22.
    Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360(9346):1623–30.CrossRefGoogle Scholar
  23. 23.
    Manzoni P. Etude du profil des délivrances de statines et des associations contenant une statine dans la population âgée de 75 ans et plus, pour la période allant de janvier 2013 à juillet 2015, en Midi-Pyrénées. Thèse en médecine. Faculté de médecine. Toulouse III. 2016. Disponible sur: http://thesesante.ups-tlse.fr/1183/1/2016TOU31003.pdf
  24. 24.
    Cholesterol Treatment Trialists’ (CTT) Collaborators, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581–90.CrossRefGoogle Scholar
  25. 25.
    Gremeaux E, Grino M, Molines C, et al. Cardiovascular secondary prevention by statin in southern French nursing home. J Nurs Home Res. 2016;2:1–6.Google Scholar

Copyright information

© Serdi and Springer-Verlag International SAS, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Service de médecine interne gériatrique, hôpital de la Cavale BlancheCHRU de BrestBrestFrance

Personalised recommendations